Analysts' ratings for Agilon Health (NYSE:AGL) over the last quarter vary from bullish to bearish, as provided by 5 analysts.

The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.

BullishSomewhat BullishIndifferentSomewhat BearishBearishTotal Ratings11210Last 30D000101M Ago000002M Ago111003M Ago00100

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $6.2, a high estimate of $9.00, and a low estimate of $3.00. Experiencing a 9.88% decline, the current average is now lower than the previous average price target of $6.88.

price target chart

Analyzing Analyst Ratings: A Detailed Breakdown

A comprehensive examination of how financial experts perceive Agilon Health is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.

AnalystAnalyst FirmAction TakenRatingCurrent Price TargetPrior Price TargetKevin FischbeckB of A SecuritiesAnnouncesUnderperform$3.00-George HillDeutsche BankLowersHold$4.00$5.00Bill SutherlandBenchmarkMaintainsBuy$9.00$9.00Sean DodgeRBC CapitalMaintainsOutperform$8.00$8.00Elizabeth AndersonEvercore ISI GroupRaisesIn-Line$7.00$5.50Key Insights:

Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent ...

Full story available on Benzinga.com